Related Experiment Video
Updated: Apr 18, 2026
Measuring Caenorhabditis elegans Life Span in 96 Well Microtiter Plates
Published on: March 18, 2011
Caenorhabditis Intervention Testing Program: the anticonvulsant levetiracetam does not extend lifespan in nematodes
Jyothi Shilpa Akella1, Brian D Onken1, Christine A Sedore2
1Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08854, USA.
Abstract:
The Caenorhabditis Intervention Testing Program aims to identify lifespan-extending interventions that are effective across diverse genetic backgrounds. Previous studies identified a role for anticonvulsants in lifespan extension in the nematode Caenorhabditis elegans . The FDA-approved anticonvulsant levetiracetam acts in C. elegans and modulates neurotransmission. However, levetiracetam effects on nematode lifespan are unknown. Here, we examine the effect of levetiracetam on the lifespan of strain representatives from three species of the Caenorhabditis genus. Our results do not reveal an effect of levetiracetam on nematode lifespan, indicating that anticonvulsants can differ in their ability to extend lifespan.
Insights
Levetiracetam, an anticonvulsant, was tested for its ability to extend lifespan in nematodes. This study found no significant lifespan extension in Caenorhabditis nematodes, suggesting not all anticonvulsants impact longevity.
Area of Science:
- Gerontology
- Neuroscience
- Molecular Biology
Background:
- The Caenorhabditis Intervention Testing Program seeks interventions that extend lifespan across different genetic backgrounds.
- Anticonvulsant drugs have shown potential in extending lifespan in the nematode Caenorhabditis elegans.
- Levetiracetam, an FDA-approved anticonvulsant, influences neurotransmission in C. elegans.
Purpose of the Study:
- To investigate the effect of levetiracetam on the lifespan of multiple Caenorhabditis species.
- To determine if levetiracetam, like other anticonvulsants, can extend nematode lifespan.
Main Methods:
- Testing the lifespan of representative strains from three Caenorhabditis species.
- Administering levetiracetam and observing survival rates.
Main Results:
- Levetiracetam did not significantly alter the lifespan of the tested Caenorhabditis nematodes.
- The study found no evidence of lifespan extension associated with levetiracetam treatment.
Conclusions:
- Levetiracetam does not appear to be a lifespan-extending intervention in these nematode models.
- Anticonvulsants exhibit varied effects on nematode lifespan, highlighting the need for specific investigation.
